Maxim Group Significantly Raises Achillion's PT, Shares Soar +15% By: Benzinga via Benzinga June 16, 2014 at 09:34 AM EDT Maxim Group analyst Jason Kolbert raised the price target on Buy rated Achillion Pharmaceuticals (NASDAQ: ACHN) from $6.00 to $22.00. ... Read More >> Related Stocks: Achison Inc